Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
URGN
#2067
UroGen Pharma Ltd. Ordinary Shares
21.700
0
+4.28%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+4.28%
Variazione Mensile
-0.60%
Variazione di 6 mesi
+14.21%
Variazione Annuale
+14.21%
Chiusura Precedente
20.810
0
Open
21.700
0
Bid
Ask
Low
21.700
0
High
21.700
0
Volume
74
Mercati
Mercato Azionario Statunitense
Salute
URGN
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
42.2 M
46.09 M
46.11 M
46.26 M
46.81 M
—
Valuation ratios
Enterprise value
411.02 M
318.92 M
405.92 M
540.91 M
843.8 M
2.11 B
Price to earnings ratio
3.82
3.6
3.48
4.13
5.76
16.97
Price to sales ratio
4.97
5.05
5.2
6.71
9.83
26.8
Price to cash flow ratio
4.72
4.72
4.49
5.17
6.9
21.28
Price to book ratio
2.6
51.87
4.28
3.69
3.61
63.46
Enterprise value to EBITDA ratio
-4.94
-3.3
-3.76
-4.37
-6.29
-17.73
Profitability ratios
Return on assets %
-0.08
-0.13
-0.18
-0.24
-0.18
-0.73
Return on equity %
-0.93
-4.26
-0.94
-0.53
-0.29
-6.03
Return on invested capital %
-311.73
-364.1
-582.81
-642.29
-348.12
-1 937.33
Gross margin %
90.27
89.94
88.5
85.34
88.07
351.85
Operating margin %
-69.61
-112.59
-182.26
-171.17
-99.65
-565.66
EBITDA margin %
-69.22
-112.74
-182.83
-172
-100.68
-568.25
Net margin %
-93.93
-152.71
-216.47
-206.24
-121.34
-696.75
Liquidity ratios
Quick ratio
8.77
5.81
5.47
3.99
3.79
19.06
Current ratio
9
6.01
5.65
4.14
3.99
19.79
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.09
0.08
0.08
0.11
0.14
0.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.4
0.43
0.49
0.59
0.66
2.17
Long term debt to total equity ratio
4.77
-13.83
-2.63
-1.31
-1.06
-18.83
Per share metrics
Operating cash flow per share
-0.64
-0.29
-0.89
-0.83
-0.88
-2.89
EBIT per share
-0.41
-0.59
-0.78
-0.87
-0.58
-2.82
EBITDA per share
-0.4
-0.59
-0.78
-0.87
-0.58
-2.82
Total debt per share
—
—
—
—
—
—
Cash per share
5.9
5.14
4.23
3.39
2.65
15.4
Net current asset value per share
6.85
5.87
5
4.12
3.51
18.5
Tangible book value per share
0.59
-0.19
-0.98
-1.96
-2.4
-5.52
Working capital per share
6.09
4.89
4.12
3.13
2.63
14.77
Book value per share
0.59
-0.19
-0.98
-1.96
-2.4
-5.52
Notizie
Il CMO di UroGen Pharma Schoenberg vende azioni per 145 mila dollari
UroGen Pharma CMO Schoenberg sells $145k in shares
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
2025 Performance Review And Future Strategy
Il titolo di Urogen Pharma Ltd raggiunge il massimo di 52 settimane a 25,2 USD
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
UroGen Pharma alla Conferenza Guggenheim: Approfondimenti strategici sul lancio di UGN-102
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Il titolo di Urogen Pharma raggiunge il massimo di 52 settimane a 23,66 USD
Urogen Pharma stock hits 52-week high at 23.66 USD
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
Il titolo di UroGen Pharma sale dopo risultati positivi della sperimentazione di Fase 3